NuVasive CEO Gregory T. Lucier purchased several of the company's shares last Friday in a transaction disclosed yesterday, according to an Insider Trading report.
Here are six quick facts about the transaction:
1. Mr. Lucier purchased 10,000 NuVasive shares.
2. The shares were purchased at $49.71 per share.
3. The total transaction reached $497,100.
4. Company shares rallied 41.61 percent from the one-year high price.
5. Company insiders hold 1.54 percent of shares and institutions hold 99 percent of shares.
6. NuVasive's market cap is $2.3 billion.